Search





Search





Markets
/
Stocks
/
rvmd
/

Revolution Medicines Inc

RVMD

Add to Watchlist

184.000USD

-4.070-2.16%

Close 07-28 16:00（ET）Quotes delayed by 15 min

36.25BMarket Cap

LossP/E TTM

Revolution Medicines Inc

184.000

-4.070-2.16%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

RVMD Cash Flow Statement

You can access the annual and quarterly cash flow statements of Revolution Medicines Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-82.15%-354.17M

-98.31%-274.24M

-58.96%-207.31M

-73.02%-221.76M

-21.10%-194.44M

-14.70%-138.29M

-29.77%-130.42M

-90.95%-128.17M

-157.34%-160.56M

-95.12%-120.56M

-94.25%-100.50M

-20.47%-67.12M

-13.11%-62.39M

-57.36%-61.79M

-41.40%-51.74M

-63.48%-55.72M

-48.10%-55.16M

-56.85%-39.27M

-35.41%-36.59M

-70.48%-34.08M

-32.94%-37.25M

-114.85%-25.03M

-95.00%-27.02M

-73.80%-19.99M

-122.28%-28.02M

1.05%-11.65M

---13.86M

---11.50M

---12.61M

---11.78M

Net income from continuing operations

-112.64%-453.82M

-87.54%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-20.45%-194.57M

-44.13%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.30M

-18.13%-68.10M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

-55.07%-57.65M

-54.01%-52.68M

-94.48%-52.94M

-62.77%-44.30M

-90.46%-37.18M

-134.34%-34.20M

-112.37%-27.22M

-168.95%-27.21M

-92.67%-19.52M

-28.72%-14.60M

---12.82M

---10.12M

---10.13M

---11.34M

Operating gains losses

19.75%2.35M

407.77%2.34M

21.99%2.33M

6.08%2.02M

-57.11%1.96M

-147.03%-759.00K

24.51%1.91M

28.12%1.91M

210.33%4.57M

13.90%1.61M

21.94%1.53M

24.37%1.49M

26.03%1.47M

30.84%1.42M

18.68%1.26M

11.86%1.20M

24.52%1.17M

15.09%1.08M

13.73%1.06M

18.08%1.07M

4.34%938.00K

8.79%941.00K

6.76%932.00K

11.84%907.00K

13.37%899.00K

25.18%865.00K

--873.00K

--811.00K

--793.00K

--691.00K

Deferred tax

----

-1672.09%-762.00K

----

65.04%-43.00K

-1206.42%-3.87M

----

---123.00K

---296.00K

----

100.00%0.00

----

108.21%359.00K

--0.00

---18.00K

---716.00K

---4.37M

----

Other non-cash items

87.17%-1.03M

70.60%-2.19M

57.00%-3.71M

40.42%-5.97M

43.59%-8.06M

-0.70%-7.44M

-90.29%-8.63M

-119.22%-10.01M

-467.89%-14.29M

-424.04%-7.39M

-32478.57%-4.53M

-492.78%-4.57M

-242.15%-2.52M

-175.36%-1.41M

-99.12%14.00K

-20.51%1.16M

38.93%1.77M

39.11%1.87M

44.26%1.58M

71.92%1.46M

135.93%1.27M

1040.56%1.34M

601.37%1.10M

1067.05%851.00K

--540.00K

---143.00K

---219.00K

---88.00K

--0.00

Change in working capital

-795.32%-16.95M

-24.63%32.25M

445.92%56.44M

9.22%-4.30M

105.16%2.44M

101.81%42.78M

809.32%10.34M

-122.28%-4.74M

-1500.98%-47.21M

257.25%21.20M

-90.89%1.14M

529.54%21.27M

58.55%-2.95M

-417.57%-13.48M

60.45%12.48M

-308.90%-4.95M

-25.49%-7.11M

9.04%4.25M

272.82%7.78M

-31.61%2.37M

47.46%-5.67M

-22.47%3.89M

-77.03%-4.50M

229.80%3.47M

-153.08%-10.79M

411.86%5.02M

---2.54M

---2.67M

---4.26M

---1.61M

-Change in receivables

----

--0.00

-100.00%0.00

100.00%0.00

-100.00%0.00

84.96%1.25M

-453.93%-945.00K

221.78%2.20M

716.18%1.48M

24.18%678.00K

-82.00%267.00K

177.29%684.00K

-123.24%-241.00K

146.63%546.00K

-48.97%1.48M

55.03%-885.00K

-7.33%1.04M

-508.01%-1.17M

1264.32%2.91M

-2975.00%-1.97M

217.30%1.12M

145.63%287.00K

115.27%213.00K

---64.00K

---954.00K

---629.00K

---1.40M

-Change in prepaid expenses

-257.07%-10.09M

33.94%-3.38M

-222.91%-5.36M

11.88%-7.36M

1189.15%6.43M

-127.00%-5.11M

600.80%4.36M

-635.95%-8.35M

-136.62%-590.00K

-149.11%-2.25M

-204.32%-870.00K

80.37%-1.14M

147.16%1.61M

618.81%4.59M

20.17%834.00K

-4801.63%-5.78M

-171.76%-3.42M

303.80%638.00K

51.20%694.00K

-81.39%123.00K

60.74%-1.26M

-88.66%158.00K

123.47%459.00K

1196.08%661.00K

-10941.38%-3.20M

178.04%1.39M

---1.96M

--51.00K

---29.00K

--501.00K

-Change in other current assets

-1480.52%-10.56M

-93237.50%-7.45M

50.40%-933.00K

-318.54%-17.27M

512.00%765.00K

-99.89%8.00K

78.31%-1.88M

-4789.77%-4.13M

38.89%125.00K

445.25%7.08M

-5568.63%-8.67M

23.94%88.00K

178.95%90.00K

-2632.10%-2.05M

---153.00K

--71.00K

---114.00K

130.45%81.00K

----

-100.00%0.00

----

-122.28%-266.00K

110.97%131.00K

--274.00K

----

--1.19M

---1.19M

--0.00

---65.00K

----

-Change in other current liabilities

63.32%5.66M

-65.36%-1.27M

-468.93%-3.97M

203.50%2.31M

62.66%3.47M

-46.56%-768.00K

47.26%1.07M

22.57%-2.23M

230.64%2.13M

95.15%-524.00K

-62.00%730.00K

42.05%-2.88M

-102.73%-1.63M

-193.65%-10.81M

-71.54%1.92M

-68.92%-4.96M

50.91%-805.00K

-37.43%-3.68M

335.23%6.75M

-18.42%-2.94M

46.26%-1.64M

21.68%-2.68M

18.95%-2.87M

27.29%-2.48M

8.79%-3.05M

-21.09%-3.42M

---3.54M

---3.41M

---3.35M

---2.83M

Cash from non-recurring investing activities

Cash from operating activities

-82.15%-354.17M

-98.31%-274.24M

-58.96%-207.31M

-73.02%-221.76M

-21.10%-194.44M

-14.70%-138.29M

-29.77%-130.42M

-90.95%-128.17M

-157.34%-160.56M

-95.12%-120.56M

-94.25%-100.50M

-20.47%-67.12M

-13.11%-62.39M

-57.36%-61.79M

-41.40%-51.74M

-63.48%-55.72M

-48.10%-55.16M

-56.85%-39.27M

-35.41%-36.59M

-70.48%-34.08M

-32.94%-37.25M

-114.85%-25.03M

-95.00%-27.02M

-73.80%-19.99M

-122.28%-28.02M

1.05%-11.65M

---13.86M

---11.50M

---12.61M

---11.78M

Investing cash flow

Net cash from continuing investing activities

-52.91%1.54M

57.53%1.93M

-4.86%3.35M

210.55%7.45M

3.13%3.27M

-47.26%1.22M

38.86%3.52M

114.39%2.40M

80.15%3.17M

-19.44%2.32M

-28.09%2.54M

-55.70%1.12M

-6.93%1.76M

143.11%2.88M

676.43%3.52M

92.53%2.53M

-47.22%1.89M

1.20%1.18M

-33.92%454.00K

176.79%1.31M

493.53%3.58M

131.03%1.17M

-37.66%687.00K

-13.19%474.00K

110.47%603.00K

134.26%506.00K

--1.10M

--546.00K

---5.76M

--216.00K

Capital expenditures

-52.91%1.54M

57.53%1.93M

-4.86%3.35M

210.55%7.45M

3.13%3.27M

-47.26%1.22M

38.86%3.52M

114.39%2.40M

80.15%3.17M

-19.44%2.32M

-28.09%2.54M

-55.70%1.12M

-6.93%1.76M

143.11%2.88M

676.43%3.52M

92.53%2.53M

-47.22%1.89M

1.20%1.18M

-33.92%454.00K

176.79%1.31M

493.53%3.58M

129.22%1.17M

-37.94%687.00K

-24.88%474.00K

76.83%603.00K

136.11%510.00K

--1.11M

--631.00K

--341.00K

--216.00K

Net cash flow from disposal of fixed assets

-52.91%1.54M

57.53%1.93M

-4.86%3.35M

210.55%7.45M

3.13%3.27M

-47.26%1.22M

38.86%3.52M

114.39%2.40M

80.15%3.17M

-19.44%2.32M

-28.09%2.54M

-55.70%1.12M

-6.93%1.76M

143.11%2.88M

676.43%3.52M

92.53%2.53M

-47.22%1.89M

1.20%1.18M

-33.92%454.00K

176.79%1.31M

493.53%3.58M

131.03%1.17M

-37.66%687.00K

-13.19%474.00K

110.47%603.00K

134.26%506.00K

--1.10M

--546.00K

---5.76M

--216.00K

Net cash flow from business transactions

----

--0.00

----

--160.00K

Net cash flow from investment products

1473.12%174.15M

119.61%76.81M

257.10%28.20M

-62.19%41.73M

94.82%-12.68M

-3.60%-391.68M

-122.47%-17.95M

360.09%110.34M

-4354.41%-244.80M

-8842.41%-378.08M

166.62%79.89M

-165.34%-42.42M

-87.47%5.75M

-143.52%-4.23M

-303.44%-119.91M

153.45%64.93M

679.79%45.91M

-84.85%9.72M

70.36%-29.72M

10.70%-121.47M

109.96%5.89M

651.91%64.11M

-70.84%-100.28M

-145.50%-136.02M

---59.11M

--8.53M

---58.70M

---55.41M

----

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

1182.29%172.62M

119.06%74.88M

215.74%24.85M

-68.25%34.28M

93.57%-15.95M

-3.29%-392.90M

-127.75%-21.47M

347.90%107.94M

-6305.36%-247.97M

-5254.76%-380.40M

162.66%77.35M

-169.78%-43.54M

-90.92%4.00M

-183.25%-7.10M

-309.05%-123.44M

150.82%62.40M

1806.67%44.02M

-86.44%8.53M

70.11%-30.18M

10.05%-122.78M

103.87%2.31M

684.76%62.95M

-68.84%-100.97M

-143.95%-136.50M

-1136.56%-59.72M

14423.21%8.02M

---59.80M

---55.95M

--5.76M

---56.00K

Financing cash flow

Cash flow from continuous financing activities

27216.25%238.74M

-58.15%365.66M

-102.06%-1.59M

3319.28%256.58M

7.90%874.00K

4.10%873.80M

7545.30%77.29M

-88.39%7.50M

-99.75%810.00K

1534.16%839.35M

-99.59%1.01M

4422.74%64.63M

106196.72%324.20M

378.78%51.36M

77747.96%248.34M

64.63%1.43M

-99.89%305.00K

622.42%10.73M

-99.81%319.00K

164.97%868.00K

11.24%282.26M

196.81%1.48M

1587.99%168.88M

-101.48%-1.34M

1812357.14%253.74M

-136.34%-1.53M

--10.01M

--90.17M

--14.00K

--4.22M

Net cash flow from debt Issuance/repayment

----

--0.00

----

Net cash flow from common stock issuance/repurchase

--226.73M

-54.94%347.92M

----

--772.05M

--74.29M

-100.00%0.00

--62.05M

--323.71M

394.44%49.92M

--248.13M

100.00%0.00

-100.00%0.00

29794.12%10.10M

-100.00%0.00

61.08%-564.00K

11.02%281.71M

-168.00%-34.00K

73821.15%167.80M

-10250.00%-1.45M

1812357.14%253.74M

163.16%50.00K

--227.00K

---14.00K

--14.00K

--19.00K

Net cash flow from preferred stock issuance/repurchase

----

-100.12%-5.00K

--9.86M

--90.17M

----

--4.33M

Proceeds from stock option exercised by employees

1270.26%12.21M

190.42%17.55M

38.12%4.14M

-12.30%6.58M

10.00%891.00K

137.39%6.04M

196.83%3.00M

191.19%7.50M

62.32%810.00K

81.60%2.55M

383.73%1.01M

80.34%2.58M

63.61%499.00K

32.77%1.40M

-34.48%209.00K

-0.21%1.43M

-45.05%305.00K

-30.48%1.06M

-70.38%319.00K

1167.26%1.43M

--555.00K

1887.06%1.52M

4208.00%1.08M

653.33%113.00K

----

35.11%-85.00K

--25.00K

--15.00K

----

---131.00K

Proceeds from issuance of warrants

5600.00%57.00K

-100.00%0.00

--3.00K

--0.00

--1.00K

--95.42M

----

Net cash flow from other financing activities

-1300.00%-252.00K

-32.75%191.00K

---5.74M

--250.00M

---18.00K

-99.97%284.00K

----

1992300.00%836.81M

----

109.91%42.00K

----

---424.00K

----

100.00%0.00

104.63%5.00K

----

---1.49M

---108.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

27216.25%238.74M

-58.15%365.66M

-102.06%-1.59M

3319.28%256.58M

7.90%874.00K

4.10%873.80M

7545.30%77.29M

-88.39%7.50M

-99.75%810.00K

1534.16%839.35M

-99.59%1.01M

4422.74%64.63M

106196.72%324.20M

378.78%51.36M

77747.96%248.34M

64.63%1.43M

-99.89%305.00K

622.42%10.73M

-99.81%319.00K

164.97%868.00K

11.24%282.26M

196.81%1.48M

1587.99%168.88M

-101.48%-1.34M

1812357.14%253.74M

-136.34%-1.53M

--10.01M

--90.17M

--14.00K

--4.22M

Net cash flow

Beginning cash balance

-28.93%388.60M

8.89%222.30M

45.78%406.35M

15.71%337.25M

-21.80%546.76M

-43.42%204.15M

-27.21%278.74M

-32.05%291.46M

328.55%699.18M

99.69%360.79M

256.15%382.92M

331.53%428.96M

48.00%163.15M

38.73%180.68M

-45.33%107.52M

-71.81%99.40M

4.63%110.23M

97.46%130.24M

684.85%196.68M

92.84%352.68M

524.38%105.35M

199.28%65.95M

-70.75%25.06M

190.43%182.88M

-75.83%16.87M

-71.53%22.04M

--85.69M

--62.97M

--69.80M

--77.41M

Current period cash flow changes

127.30%57.19M

-51.46%166.30M

-146.74%-184.05M

643.30%69.10M

48.61%-209.51M

1.25%342.61M

-237.01%-74.59M

72.37%-12.72M

-253.39%-407.72M

2030.45%338.39M

-130.25%-22.13M

-667.35%-46.03M

2554.39%265.81M

12.37%-17.53M

210.10%73.16M

105.20%8.11M

-104.38%-10.83M

-150.78%-20.00M

-262.48%-66.45M

1.16%-156.00M

48.98%247.33M

862.77%39.40M

164.25%40.90M

-794.67%-157.82M

2530.60%166.01M

32.14%-5.17M

---63.65M

--22.72M

---6.83M

---7.61M

Ending cash balance

32.19%445.80M

-28.93%388.60M

8.89%222.30M

45.78%406.35M

15.71%337.25M

-21.80%546.76M

-43.42%204.15M

-27.21%278.74M

-32.05%291.46M

328.55%699.18M

99.69%360.79M

256.15%382.92M

331.53%428.96M

48.00%163.15M

38.73%180.68M

-45.33%107.52M

-71.81%99.40M

4.63%110.23M

97.46%130.24M

684.85%196.68M

92.84%352.68M

524.38%105.35M

199.28%65.95M

-70.75%25.06M

190.43%182.88M

-75.83%16.87M

--22.04M

--85.69M

--62.97M

--69.80M

Free cash flow

-79.92%-355.70M

-97.95%-276.16M

-57.28%-210.66M

-75.55%-229.21M

-20.75%-197.70M

-13.54%-139.51M

-30.00%-133.94M

-91.33%-130.57M

-155.23%-163.73M

-90.03%-122.88M

-86.44%-103.03M

-17.17%-68.24M

-12.45%-64.15M

-59.87%-64.66M

-49.19%-55.26M

-64.56%-58.24M

-39.74%-57.05M

-54.36%-40.45M

-33.69%-37.04M

-72.94%-35.39M

-42.64%-40.83M

-115.45%-26.20M

-85.16%-27.71M

-68.67%-20.46M

-121.08%-28.62M

-1.42%-12.16M

---14.96M

---12.13M

---12.95M

---11.99M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Revolution Medicines Inc Generate?



Revolution Medicines Inc generated -897.74M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Revolution Medicines Inc's Operating Cash Flow Change Year Over Year?



Revolution Medicines Inc's operating cash flow increased by -61.05% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Revolution Medicines Inc Spend on Capital Expenditures?



Revolution Medicines Inc spent 15.99M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Revolution Medicines Inc's Financing Cash Flow Changed?



Revolution Medicines Inc used 621.52M in financing activities in the latest quarter.

What is free cash flow and why does it matter for RVMD?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Revolution Medicines Inc’s free cash flow in the latest quarter?



Free cash flow was -913.73M reflecting a -60.94% change from the previous year.